Inception Return
(5/24/2005)
|
5.44 %
|
YTD Return
|
10.88 %
|
|
NAVPS
(1/22/2021)
|
$11.67
|
Change
|
($0.02) / -0.15 %
|
|
Growth of $10,000
(As of December 31, 2020)
|
MER
|
1.62 %
|
Assets ($mil)
|
$1,229.02
|
Rank (1Yr)
|
-
|
Std Dev (3Yr)
|
8.17 %
|
Volatility Ranking (3Yr)
|
3/10
|
RRSP Eligibility
|
Yes
|
Load
|
No Load
|
Max Front End
|
-
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
The objective of the fund is to provide a combination of regular U.S. dollar monthly income and modest capital growth. The fund invests primarily in U.S. fixed-income securities such as government and corporate bonds, notes, asset-backed securities and preferred shares. The fund also invests in high-quality equity securities of U.S. companies.
|
Management Co.
RBC Global Asset Management Inc.
Managers
Jane Lesslie, Frank Gambino, Soo Boo Cheah, Brad Willock, Stuart Morrow
|
Asset Allocation
(As of September 30, 2020)
|
Sector Allocation
(As of September 30, 2020)
|
Geographic Allocation
(As of September 30, 2020)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
RBC $U.S. High Yield Bond Fund Series O | Domestic Bonds | Fixed Income | Canada | 3.78% |
RBC Emerging Markets Bond Fund Series O | Foreign Bonds | Fixed Income | Multi-National | 3.75% |
Apple Inc | US Equity | Technology | United States | 3.43% |
Microsoft Corp | US Equity | Technology | United States | 3.02% |
United States Treasury 1.75% 15-May-2023 | Foreign Bonds | Fixed Income | United States | 2.90% |
Cash & Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.84% |
United States Treasury 2.00% 15-Feb-2025 | Foreign Bonds | Fixed Income | United States | 2.31% |
United States Treasury 1.63% 15-Feb-2026 | Foreign Bonds | Fixed Income | United States | 1.54% |
Johnson & Johnson | US Equity | Healthcare | United States | 1.48% |
UnitedHealth Group Inc | US Equity | Healthcare | United States | 1.08% |
Performance Data
(As of December 31, 2020)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
2.07
|
6.63
|
10.73
|
10.88
|
10.88
|
7.10
|
7.60
|
6.32
|
Benchmark
|
3.22
|
9.57
|
15.83
|
13.35
|
13.35
|
8.06
|
9.14
|
6.65
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Calendar Return (%)
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
Fund
|
10.88
|
14.85
|
-3.54
|
10.07
|
6.67
|
-1.15
|
7.38
|
9.54
|
7.96
|
1.93
|
Benchmark
|
13.35
|
17.91
|
-5.58
|
16.32
|
5.51
|
-1.74
|
2.93
|
10.87
|
11.22
|
-1.42
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
MSCI ESG Fund Metrics (As of January 01, 2021)
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.